Free shipping on all orders over $ 500

E6201

Cat. No. M30350
E6201 Structure
Synonym:

ER-806201

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

E6201 (ER-806201) is an ATP-competitive dual kinase inhibitor of MEK1 and FLT3. E6201 inhibits MEK1- induced ERK2 phosphorylation with an IC50 value of 5.2 nM, MKK4-induced JNK phosphorylation with an IC50 value of 91 nM, and MKK6-induced p38 MAPK phosphorylation with an IC50 value of 19 nM. Anti-tumor and anti-psoriasis efficacy.

Chemical Information
Molecular Weight 389.44
Formula C21H27NO6
CAS Number 603987-35-5
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jangsoon Lee, et al. Breast Cancer Res Treat. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

[2] Hani M Babiker, et al. Invest New Drugs. E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

[3] Gautham Gampa, et al. Drug Metab Dispos. Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases

[4] Kenzo Muramoto, et al. J Pharmacol Exp Ther. E6201, a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1: in vivo effects on cutaneous inflammatory respon䲧癐Ỵ癑㧀癏羹瘸盋晸Ƙ

[5] Masaki Goto, et al. J Pharmacol Exp Ther. E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 䲧癐Ỵ癑㧀癏羹瘸盋晸ƘƌƘÐ�瘺嶁瘶Ѐ瑖抩䀹⹜ࢹƘÐèࢹ彿抪奋抪巫抪䬄ࢹ嫼ࢹ彿抪嫰ࢹ塚抪嫼

Related MEK Products
Glycinexylidide

Glycinexylidide (GX) is the active metabolite of Lidocaine.

Xantocillin

Xantocillin (Xanthocillin X) is a marine agent extracted from Penicillium commune, induces autophagy through inhibition of the MEK/ERK pathway.

MEK-IN-6 hydrate

MEK-IN-6 hydrate is a MEK inhibitor.

MS934

MS934 is a novel improved VHL-recruiting MEK 1/2 degrader.

Nedometinib

Nedometinib is a tyrosine kinase inhibitor targeting to MEK1.

  Catalog
Abmole Inhibitor Catalog




Keywords: E6201, ER-806201 supplier, MEK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.